Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Cellular and Molecular Biology

Tissue transglutaminase (TG2) constitutively suppresses autophagy in pancreatic cancer cells

Bulent Ozpolat, Ugur Akar, Kapil Mehta, Yasuko Kondo and Gabriel Lopez-Berestein
Bulent Ozpolat
UT M.D. Anderson Cancer Ctr., Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ugur Akar
UT M.D. Anderson Cancer Ctr., Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kapil Mehta
UT M.D. Anderson Cancer Ctr., Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasuko Kondo
UT M.D. Anderson Cancer Ctr., Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriel Lopez-Berestein
UT M.D. Anderson Cancer Ctr., Houston, TX
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI:  Published May 2007
  • Article
  • Info & Metrics
Loading
AACR Annual Meeting-- Apr 14-18, 2007; Los Angeles, CA

Abstract

2762

Elevated expression of tissue transglutaminase (TG2) in cancer cells has been implicated in the development of drug resistance and metastatic phenotypes. However, the role and the mechanisms that regulate TG2 expression remain elusive. Here we provide evidence that Protein Kinase C-delta (PKCδ) regulates TG2 expression, which in turn inhibits autophagy, a type II programmed cell death, in pancreatic cancer cells that are frequently insensitive to standard chemotherapeutic agents. Rottlerin, a PKCδ-specific inhibitor, downregulated the expression of TG2 mRNA and protein and induced growth inhibition without inducing apoptosis in pancreatic cancer cells. No sign of apoptosis was detected by Annexin V, PARP cleavege and PI staining (lack of sub-G1 cell population) assays. Inhibition of PKCδ by rottlerin or knock-down of TG2 protein by a TG2-specific siRNA resulted in a marked increase in autophagy demonstrated by presence of autophagic vacuoles in the cytoplasm detected by phase contrast microscopy and tranmission electron microscopy, formation of the acidic vesicular organelles by acridine orange staining, and a marked induction membrane association of microtubule-associated protein light chain 3 (LC3)-II by Western blotting, important hallmarks of autophagy. Furthermore, inhibition of TG2 by Rottlerin or by the siRNA led to accumulation of green flourescent protein taged LC3-II (GFP-LC3-II) in autophagosomes in pancreatic cancer cells transfected with GFP-LC-3(GFP-ATG8) expression vector. Treatment of TG2 negative cells with rottlerin under optimal conditions failed to produce any increase in LC3-II accumulation, indicating that the induction of autophagy by Rottlerin involved TG2. Knockdown of Beclin-1, a specific autophagy promoting protein and the product of Becn1 (ATG6), inhibited rottlerin- and TG2 siRNA-induced autophagy, indicating that Beclin-1 is required for the process. A specific mTOR inhibitor, rapamycin, failed to induce autophagy in these cells, indicating that rottlerin-induced autophagy is not mediated by mTOR. These results revealed that PKCdelta plays a critical role in the expression of TG2, which in turn regulates autophagy. In conclusion, these results suggest a novel mechanism of regulation of TG2 and autophagy in pancreatic cancer cells.

Footnotes

  • 98th AACR Annual Meeting-- Apr 14-18, 2007; Los Angeles, CA

  • American Association for Cancer Research
Previous
Back to top
Cancer Research: 67 (9 Supplement)
May 2007
Volume 67, Issue 9 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Tissue transglutaminase (TG2) constitutively suppresses autophagy in pancreatic cancer cells
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Tissue transglutaminase (TG2) constitutively suppresses autophagy in pancreatic cancer cells
Bulent Ozpolat, Ugur Akar, Kapil Mehta, Yasuko Kondo and Gabriel Lopez-Berestein
Cancer Res May 1 2007 (67) (9 Supplement) 2762;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Tissue transglutaminase (TG2) constitutively suppresses autophagy in pancreatic cancer cells
Bulent Ozpolat, Ugur Akar, Kapil Mehta, Yasuko Kondo and Gabriel Lopez-Berestein
Cancer Res May 1 2007 (67) (9 Supplement) 2762;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Cellular and Molecular Biology

  • Abstract SY29-01: Functions of wild type and mutant p53
  • Abstract SY34-02: The impact of O2 availability on human cancer
  • Abstract SY19-01: Cell to cell variability in the responses of tumor cells to death ligands
Show more 3

Autophagy and Drug Response: Poster Presentations

  • Bay 43-9006 induces autophagy in colon cancer cells associated with reduced sensitivity to camptothecin
  • The role of Beclin 1 interacting proteins and Beclin 1 post-translational modification in autophagy regulation.
  • AKT signaling pathway mediates tamoxifen-inhibition of cholangiocarcinoma growth in vitro and in vivo
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement